Community observations, not medical advice.Always speak with a qualified healthcare professional.
supplement × Metabolic Health

Berberine for Fatty Liver (NAFLD)

Isoquinoline plant alkaloid that activates AMP-activated protein kinase (AMPK); trials show blood-glucose-lowering effects in type 2 diabetes approaching those of metformin, though GI side effects are common.

-published research: study records
-published research: findings
Not formally gradedcertainty of the research
On this pageOverviewEvidenceCommunity outcomesRelated
Why Berberine for Fatty Liver (NAFLD)?

The connection

Non-alcoholic fatty liver disease. Fat accumulation in the liver, often linked to insulin resistance and obesity.

Also known as: Berberine HCl

Published research

Berberine × Fatty Liver (NAFLD): at a glance

Every published result for this pair, extracted and audited.

Published research

Berberine / Fatty Liver (NAFLD): publication years

What this means: Counts describe research quantity, not treatment effectiveness or certainty.

Berberine / Fatty Liver (NAFLD): publication years (publications, count)
CategoryPublications (count)
20231
20242
20252
20261
← Zoom out: all evidence for BerberineZoom out: compare compounds for Fatty Liver (NAFLD) →
Published research

Berberine × Fatty Liver (NAFLD): the evidence base

Hand-selected PubMed studies, linked to the originals.

6studies referenced
6journals
2023–2026publication range

Ordered by strength of evidence, then result direction.

01Adjunctive berberine for schizophrenia with metabolic syndrome: a systematic review and meta-analysisXie K, et al. · Frontiers in psychiatry · 2026PMID 42433212 ↗02Clinical Efficacy of Curcumin, Resveratrol, Silymarin, and Berberine on Cardio-Metabolic Risk Factors Among Patients With Type 2 Diabetes Mellitus: A Systemic Review and Bayesian Network Meta-AnalysisMiao R, et al. · Phytotherapy research : PTR · 2025PMID 40439602 ↗03Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trialsLiu D, et al. · Frontiers in pharmacology · 2025PMID 40740996 ↗04The Effect of Berberine Supplementation on Glycemic Control and Inflammatory Biomarkers in Metabolic Disorders: An Umbrella Meta-analysis of Randomized Controlled TrialsNazari A, et al. · Clinical therapeutics · 2024PMID 38016844 ↗05The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic reviewNie Q, et al. · Journal of translational medicine · 2024PMID 38429794 ↗06Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsBlais JE, et al. · Drugs · 2023PMID 36941490 ↗
Search PubMed ↗View on PubChem ↗Find clinical trials ↗

Community experiences

Contributors volunteered; this does not establish treatment effectiveness or population incidence.

Reported changes

No publishable community breakdown is available. This does not establish that no reports exist.

Share your experience
Important: This page reflects observational, aggregate-only community reporting and independent published research. It is not medical advice, and it does not claim any compound treats, cures, or is effective for any condition. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or treatment.